Insights On Trial Design

1. Microsatellite Instability Assay For Response To Immunotherapy
   6/22/2018

   MSI assay for sensitive detection of 5 mononucleotide repeat markers in tumor FFPE specimens.

2. Immune Landscape Signatures For Characterization Of Tumor Microenvironment And Response To Therapy
   6/22/2018

   Gene expression and analysis for detection of 11 Immune Landscape Signatures.

3. A Proactive Approach To Ebola Vaccine Development
   6/21/2018

   Best practices for rapid test development and regulatory approvals.

4. Fighting Cancer: Biomarkers For Immuno-Oncology Clinical Trials
   6/21/2018

   Using anatomic pathology for biomarker development in clinical trials can help predict and assess how a patient will respond to immuno-oncology therapies

5. Minimal Residual Disease: Finding The Right Test For The New Definition Of Remission
   6/21/2018

   Measurement of Residual Disease for improved oncology trial outcomes - what factors make an MRD test most effective plus explore the pros and cons of various MRD measurement approaches.

6. Planning And Implementing Biomarker Testing For immuno-Oncology Trials
   6/14/2018

   Exploring the challenges with the diverse clinical biomarker requirements.

7. Immunotherapy And PD-L1: The Future Of Precision Medicine
   6/14/2018

   Advances in precision medicine lead to new trends in immunotherapy.

8. Using Advanced Techniques For Protein Bioanalysis
   6/14/2018

   Overcoming hurdles in a regulated setting.

9. Subject Recruitment Materials: Understanding The Requirements For IRB Review
   6/11/2018

   A breakdown of regulatory guidances and a clear picture of what the IRB needs to see.

10. Clinical Study Sites Struggle To Manage Responses To Ad Campaigns
    6/11/2018

    Solutions to manage an overwhelming response to a media campaign.